Adjuvant durvalumab after concurrent chemoradiotherapy for patients with unresectable stage III NSCLC harbouring uncommon genomic alterations
Autor: | Cortiula, Francesco, De Ruysscher, Dirk, Steens, Michelle, Wijsman, Robin, van der Wekken, Anthonie, Alberti, Martina, Hendriks, Lizza E.L. |
---|---|
Zdroj: | In European Journal of Cancer May 2023 184:172-178 |
Databáze: | ScienceDirect |
Externí odkaz: |